Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-24 @ 1:37 PM
NCT ID:
NCT03469895
Brief Summary:
Efficacy of BCR Inhibitors in the Treatment of Autoimmune Cytopenias Associated with Chronic Lymphocytic Leukemia (CLL): A Retrospective Analysis of the French Innovative Leukemia Organization (FILO)
Detailed Description:
The investigators of the study propose a card of data collection, validated by the scientific council of the group FILO.
The data to be collected are entered on an e-CRF made available to the investigators on a secure site.
The main data collected are as follows
* anonymized demographic data
* Clinical and Biological Data of CLL at Diagnosis
* Previous treatments of LLC and CAI
* clinical and laboratory data at the time of initiation of BCRi treatment
* response to treatment with BCRi
* tolerance to BCRi treatment
* Progression under treatment with BCRi
* Recent news
Study:
NCT03469895
Study Brief:
Protocol Section:
NCT03469895